The Role of Compounding Pharmacies in the Ketamine Therapy Field
Peter Koshland, PharmD, CEO of Koshland Pharm and a practicing pharmacist, discusses the role of the pharmacist in ketamine therapy.
Pharmacy Times interviewed Peter Koshland, PharmD, CEO of Koshland Pharm and a practicing pharmacist, on the current role of the pharmacist in ketamine therapy. Koshland’s compounding pharmacy is based in San Francisco and has worked in the ketamine therapy space since the FDA approval of the drug.
During the discussion, Koshland addresses how compounding pharmacies and clinics work to provide ketamine therapy to patients, and whether compounding pharmacies are connected to prescribing clinics in terms of reporting adverse effects to a ketamine dosage experienced by patients, or any other feedback regarding the results of a ketamine dosage.
